Paid Clinical Trials in West Valley City, UT
As of August 2026, 79 paid clinical trials are recruiting in West Valley City, Utah. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
West Valley City offers studies at sites including START Mountain Region for conditions such as Advanced Solid Tumor, Colorectal Cancer, Solid Tumor, Triple Negative Breast Cancer. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in West Valley City
Trials by drug in West Valley City
Filter results
Newly added in West Valley City
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
76 clinical trials
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
A Phase 1/1b Study of IAM1363 in HER2 Cancers
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLC
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
A Study of LY4175408 in Participants With Advanced Cancer
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Safety/Efficacy Study of CID-078 in Patients With Advanced Solid Tumor Malignancies
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal Cancer
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Study in Advanced Solid Tumor Patients
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid Tumors
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Top Research Study Locations in West Valley City
Researchers run research studies in West Valley City, UT at 24 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| START Mountain Region | Colorectal Cancer, Advanced Solid Tumor, Gastric Cancer | 41 |
| START Mountain Region, LLC | Adenocarcinoma of Esophagus, Biliary Tract Carcinoma, Bladder Cancer | 4 |
| GSK Investigational Site | Neoplasms, Neoplasms, Prostate, Solid Tumors | 3 |
| START Mountain | Advanced Solid Tumor, Advanced Breast Cancer, Breast Neoplasms | 3 |
| START Mountain Region, LLC. | Participants With Advanced Solid Tumor Malignancies, Advanced Solid Tumor, Metastatic Solid Tumor | 3 |
| Kalo Clinical Research | Diabetes Mellitus, Type 2, Metabolic Syndrome, Obesity | 2 |
| South Texas Accelerated Research Therapeutics (START) Mountain Region | Advanced Solid Tumors, CCNE1 Amplified Advanced Solid Tumors, Cholangiocarcinoma | 2 |
| ALX Center 4 | CRC (Colorectal Cancer), Colo-rectal Cancer, ESCC | 1 |
| Avenzo Therapeutics Recruiting Site | Biliary Tract Cancer (BTC), Epithelial Tumor, Locally Advanced | 1 |
| Biotheryx Investigative Site | Breast Cancer | 1 |
| ChronicleBio | Chronic Migraine, Episodic Migraine | 1 |
| Clinical Study Site | Locally Advanced / Metastatic Solid Tumors | 1 |
| Holy Cross Hosp Jordan Valley West | Lumbar Spinal Stenosis | 1 |
| Jordan Valley Med Ctr West Valley | Lumbar Spinal Stenosis | 1 |
| Kalo Clinical Research - West Valley City | Diabetic Peripheral Neuropathic Pain | 1 |
| START - Mountain Region | Advanced or Metastatic Castration-Resistant Prostate Cancer (mCRPC), Advanced or Metastatic ER+ HER2- Breast Cancer (mBC), Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) | 1 |
| START Center for Cancer Care | Advanced Solid Tumor | 1 |
| START Center for Cancer Research | Breast Cancer, Cervical Cancer, Endometrial Cancer | 1 |
| START Mountan Region | Advanced Solid Tumor | 1 |
| START Moutain Region | GI Cancers | 1 |
| START, Mountain Region | Breast Cancer, Colo-rectal Cancer, Lung Cancer (Non-Small Cell) | 1 |
| START- Mountain Region | G12D Mutated KRAS, Pancreatic Ductal Adenocarcinoma (PDAC) | 1 |
| South Texas Accelerated Research Therapeutics Mountain Region | Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms, Gastroesophageal Junction Adenocarcinoma | 1 |
| Vamos Health | Chronic Pain Management, Osteoarthritis | 1 |
Active & Upcoming Studies in West Valley City (2026)
Recruiting trials in West Valley City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (57 active studies)
- Study of TUB-040 in Patients With Recurrent or Progressive Uterine Cancer After Chemotherapy and Immune Therapy · Phase 1, Phase 2 · Tubulis GmbH
- Study of Oral MRT-2359 With Apalutamide in Prostate Cancer · Phase 2 · Monte Rosa Therapeutics, Inc
Neurology & pain (3 active studies)
- The Beat Pain Better Trial · Phase 3 · University of Utah
- A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults · Phase 2 · Ipsen
Diabetes & metabolic (2 active studies)
- A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes · Phase 2 · Eli Lilly and Company
- A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events · Cleerly, Inc.
Common conditions studied in West Valley City
- Advanced Solid Tumor (10 active studies)
- Colorectal Cancer (7 active studies)
- Solid Tumor (7 active studies)
- Triple Negative Breast Cancer (7 active studies)
- Ovarian Cancer (6 active studies)
- Breast Cancer (5 active studies)
Leading research sponsors in West Valley City
- Eli Lilly and Company
- AbbVie
- GlaxoSmithKline
- IDEAYA Biosciences
- Biohaven Therapeutics Ltd.
Frequently asked questions
How many paid clinical trials are currently recruiting in West Valley City?
There are approximately 79 recruiting clinical trials in West Valley City, Utah listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in West Valley City pay participants?
Most recruiting trials in West Valley City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in West Valley City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in West Valley City?
The most common conditions under active study in West Valley City include Advanced Solid Tumor (10), Colorectal Cancer (7), Solid Tumor (7), Triple Negative Breast Cancer (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in West Valley City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in West Valley City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in West Valley City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in West Valley City?
Recruiting research sites in West Valley City include START Mountain Region, START Mountain Region, LLC, GSK Investigational Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in West Valley City right now?
The largest active categories in West Valley City are Cancer & tumors (57), Neurology & pain (3), Diabetes & metabolic (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.